Hypoxic Chamber Replacement Shell
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), specifically the Center for Biologics Evaluation and Research (CBER) / Office of Vaccines Research and Review (OVRR), is seeking a Hypoxic Chamber Replacement Shell via a Combined Synopsis/Solicitation (RFQ). This requirement is for an existing Coy Lab Products Model 8375065 chamber, which has a cracking outer shell impacting experiments. This opportunity is a Total Small Business Set-Aside. Quotes are due June 17, 2026, by 1:00 PM Central Time.
Scope of Work
The requirement is for one (1) Hypoxic Chamber Replacement Shell, similar to Coy Lab Products Items 8375095 & 8526130, specifically for a Model 8375065 Hypoxic Chamber. Key technical specifications include:
- Base two-person (4 port) Glove Box with controlled temperature, pressure, O2, CO2, and humidity.
- Internal workspace dimensions: 59" L x 23" D x 23" H.
- Airlock for transferring samples and supplies without altering the internal environment.
- Digital controls for Airlock and Glove Box Temperature and Humidity.
- Anaerobic Kit for Hypoxic Glove Boxes.
Contract Details
- Contract Type: Firm-Fixed Price.
- Pricing: FOB Destination, inclusive of all shipping, handling, and delivery charges.
- Period of Acceptance: Offerors must hold prices firm through September 30, 2026.
- NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing.
- Small Business Size Standard: 1,000 employees.
- Set-Aside: Total Small Business.
Submission & Evaluation
- Submission Deadline: June 17, 2026, by 1:00 PM Central Time.
- Submission Method: Email to howard.nesmith@fda.hhs.gov, referencing Solicitation Number 75F40126Q134291.
- Evaluation: Award will be made to the lowest price technically acceptable and responsible offeror. Evaluation will prioritize Technical Acceptability, then Price.
- Technical Acceptability: Determined by descriptive material demonstrating compliance with all technical requirements.
- Eligibility: Offerors must be registered and active in SAM.gov by the submission deadline and possess a Unique Entity Identifier (UEI).
- Accessibility: A written Accessibility Conformance Report (ACR) based on the Voluntary Product Accessibility Template (VPAT) is required for any item not in compliance with 508 standards.
- Document Format: Electronic submissions must not contain macros; submissions with macros will be considered non-responsive.
Contact Information
For questions, contact Howard Nesmith via email at howard.nesmith@fda.hhs.gov or phone at 301-796-2138.